Literature DB >> 21378750

Hydrophobicity as a driver of MHC class I antigen processing.

Lan Huang1, Matthew C Kuhls, Laurence C Eisenlohr.   

Abstract

The forces that drive conversion of nascent protein to major histocompatibility complex (MHC) class I-restricted peptides remain unknown. We explored the fundamental property of overt hydrophobicity as such a driver. Relocation of a membrane glycoprotein to the cytosol via signal sequence ablation resulted in rapid processing of nascent protein not because of the misfolded luminal domain but because of the unembedded transmembrane (TM) domain, which serves as a dose-dependent degradation motif. Dislocation of the TM domain during the natural process of endoplasmic reticulum-associated degradation (ERAD) similarly accelerated peptide production, but in the context of markedly prolonged processing that included nonnascent species. These insights into intracellular proteolytic pathways and their selective contributions to MHC class I-restricted peptide supply, may point to new approaches in rational vaccine design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378750      PMCID: PMC3102268          DOI: 10.1038/emboj.2011.62

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

Review 1.  Posttranslational quality control: folding, refolding, and degrading proteins.

Authors:  S Wickner; M R Maurizi; S Gottesman
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.

Authors:  Tatiana N Golovina; E John Wherry; Timothy N J Bullock; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

3.  Detecting and measuring cotranslational protein degradation in vivo.

Authors:  G C Turner; A Varshavsky
Journal:  Science       Date:  2000-09-22       Impact factor: 47.728

Review 4.  Plumbing the sources of endogenous MHC class I peptide ligands.

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Immunol       Date:  2006-11-30       Impact factor: 7.486

Review 5.  Protein misfolding and human disease.

Authors:  Niels Gregersen; Peter Bross; Søren Vang; Jane H Christensen
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

6.  Association of protein biogenesis factors at the yeast ribosomal tunnel exit is affected by the translational status and nascent polypeptide sequence.

Authors:  Uta Raue; Stefan Oellerer; Sabine Rospert
Journal:  J Biol Chem       Date:  2007-01-17       Impact factor: 5.157

Review 7.  Rethinking peptide supply to MHC class I molecules.

Authors:  Laurence C Eisenlohr; Lan Huang; Tania N Golovina
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

8.  The major substrates for TAP in vivo are derived from newly synthesized proteins.

Authors:  E A Reits; J C Vos; M Grommé; J Neefjes
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

9.  A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteins.

Authors:  Eva Schlosser; Carolina Otero; Christine Wuensch; Benedikt Kessler; Mariola Edelmann; René Brunisholz; Ingo Drexler; Daniel F Legler; Marcus Groettrup
Journal:  EMBO Rep       Date:  2007-09-14       Impact factor: 8.807

10.  Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.

Authors:  G Lautscham; S Mayrhofer; G Taylor; T Haigh; A Leese; A Rickinson; N Blake
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  15 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

2.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.

Authors:  Diego Chowell; Sri Krishna; Pablo D Becker; Clément Cocita; Jack Shu; Xuefang Tan; Philip D Greenberg; Linda S Klavinskis; Joseph N Blattman; Karen S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

3.  Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope.

Authors:  Gabriela L Cosma; Jenna L Lobby; Elizabeth J Fay; Nicholas A Siciliano; Ryan A Langlois; Laurence C Eisenlohr
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

4.  UBQLN4 recognizes mislocalized transmembrane domain proteins and targets these to proteasomal degradation.

Authors:  Rigel Suzuki; Hiroyuki Kawahara
Journal:  EMBO Rep       Date:  2016-04-22       Impact factor: 8.807

Review 5.  Perception of self: distinguishing autoimmunity from autoinflammation.

Authors:  Tessa S van Kempen; Mark H Wenink; Emmerik F A Leijten; Timothy R D J Radstake; Marianne Boes
Journal:  Nat Rev Rheumatol       Date:  2015-05-12       Impact factor: 20.543

6.  Single Amino Acid Deletion at N-Terminus of the Target Antigen in DNA Vaccine Induces Altered CD8+ T Cell Responses against Tumor Antigen.

Authors:  Takashi Imai
Journal:  Vaccines (Basel)       Date:  2021-05-21

7.  Premature translational termination products are rapidly degraded substrates for MHC class I presentation.

Authors:  Joshua R Lacsina; Odessa A Marks; Xiongfei Liu; David W Reid; Sujatha Jagannathan; Christopher V Nicchitta
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

8.  SGTA regulates the cytosolic quality control of hydrophobic substrates.

Authors:  Lydia Wunderley; Pawel Leznicki; Aishwarya Payapilly; Stephen High
Journal:  J Cell Sci       Date:  2014-09-01       Impact factor: 5.285

9.  Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS).

Authors:  Frédéric Ebstein; Martin Keller; Annette Paschen; Peter Walden; Michael Seeger; Elke Bürger; Elke Krüger; Dirk Schadendorf; Peter-M Kloetzel; Ulrike Seifert
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

10.  Elimination of a signal sequence-uncleaved form of defective HLA protein through BAG6.

Authors:  Koki Yamamoto; Mizuki Hayashishita; Setsuya Minami; Kanji Suzuki; Takumi Hagiwara; Aya Noguchi; Hiroyuki Kawahara
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.